in-cos Cat 30/3/09 18:15 Page 84
84
C.H. Erbslöh KG J150 Canfield Scientific Europe, BV F855 CBB Developpement H825
Düsseldorfer Straße 103, Krefeld, North Rhine-Westphalia, Bos en Vartlaan 90, Amstelveen, Netherlands, 1181 AE 9 Rue Du Clos Courtel, Rennes, France, F-35700
Germany, 47809 T: + 31 6 29 47 95 14 F: + 31 2 06 38 57 28 T: + 33 2 99 38 33 30 F: + 33 2 99 63 76 88
T: + 49 21 51 52 53 51 F: + 49 21 51 52 51 06 E:
peter.kollias@canfieldsci.com W:
www.canfieldsci.com/ E:
roland.conanec@cbb-developpement.com
E:
ckuepper@che-kg.de;
wstauffer@che-kg.de W:
www.cbb-developpement.com
W:
www.cherbsloeh.de
The C.H. Erbslöh Group offers a wide range of raw and auxiliary Canfield Scientific, Inc., is the global leader in imaging systems CBB Développement offers companies its skills in
substances supplied by strongly innovative and globally acting services and products for scientific research and healthcare biotechnologies and fine chemistry (fermentation and enzymatic
producers. The range of products comprises active and care applications, including the pharmaceutical, biotechnology, processes) for the development of new cosmetic ingredients.
products, surfactants, film-forming and rheology-modifying cosmetics, medical and skin care industries. With new EMEA CBB offers research and consulting services: scientific meetings,
products for all cosmetic applications. The C.H. Erbslöh KG, headquarters in Amsterdam, The Netherlands, Canfield Scientific technological survey, product development, molecules
Krefeld, Germany represents the following producers: AloeCorp, Europe, bv is now positioned to deliver the same quality and qualification, partner searches, and promotes, with the support
Alberdingk Boley, BASF Beauty Care Solutions France, B&T, breadth of expertise throughout Europe, the Middle East and of the Regional Council of Bretagne, the overall cosmetic know-
Beraca, Biochemica, Bluestar Silicones, BENEO-Orafti/Gova, Africa. Stop by our booth F855 to see the latest in 3D imaging how of this French region. At in-cosmetics 2009, CBB will
BENEO-Remy, Copalis, Color-Clay, HallStar, Hydrior, technologies and state-of-the-art clinical research systems. promote some of its recent developments (bifunctional actives,
Interpolymer, Kelisema, Pacifique Sud, Phenbiox, Rhodia original preservatives) and will announce its 4th international
Novecare, Solabia, R.T. Vanderbilt. Biopolymers Symposium, POLYMERIX 2009, Rennes, 28-29
May.
CAC / Farpoint L650 Caregen Co., Ltd. F405 CeeTox, Inc. E860
123 N.Orchard St. Bldg.4A, Ormond Beach, Florida, United 690-3 Caregen Building, Geumjeong-dong, Gunpo-si, 4717 Campus Dr. Kalamazoo, MI 49008, USA
States, 32714 Gyeonggi-do, South Korea, 435-862 T:. +1 269 532 3800 F: +1 269 544 1077
T: +1 386 673 7566.26 F: +1 386 676 0055 T: + 82 3 14 52 38 67 F: + 82 3 14 52 38 69 E:
info@ceetox.com
E:
barbara@conaloe.com W:
www.conaloe.com E:
fiona@caregen.co.kr W:
www.caregen.co.kr W:
www.ceetox.com
For further information, please visit our stand Caregen is a global leader in the development and manufacture CeeTox, Inc. is the leader for in vitro toxicology, with cutting edge
of Growth Factor and Biomimetic Peptides. Our service, based models that help identify new products with the lowest risk for
on years of extensive experience of innovative active ingredients, toxicity and the highest probability for success. Worldwide
can meet all of your requirements to find quality raw materials. demand to eliminate animal testing led CeeTox to adapt its
Caregen is the world`s first ever company to register Growth robust, multi-parameter approach to meet the needs of cosmetic
Factors in CTFA and posses various Growth Factor biomimetic and chemical manufacturers. CeeTox has developed a range of
peptide patents all around the world. Caregen develops custom in vitro screens that offer alternatives to animal tests in support of
peptides and is also engaged in private labeling in the finished regulations such as REACH and Amendment 7 to the Cosmetics
product market. Directive. Validated methods include tests for dermal corrosion
and irritation, ocular corrosion, photo toxicity, and cutaneous
absorption, and several others are currently in validation
Campo Research K10 Cargill Europe BVBA A360 Centre for Skin Sciences,
University of Bradford G585
Level 31, 6 Battery Road, Singapore, 49909 Bedrijvenlaan 9, Mechelen, Belgium, 2800
T: + 65 6 38 33 203 F: + 65 6 38 33 632 T: + 32 1 54 00 539 F: + 32 1 54 00 592 School of Life Sciences, University of Bradford, Bradford,
E:
sales@campo-research.com W:
www.campo-research.com E:
nicole_myttenaere@cargill.com W:
www.cargill.com/ West Yorkshire, UK, BD7 1DP
T: + 44 (0) 1274 235949 F: + 44 (0) 1274 309742
E:
c.h.dove@brad.ac.uk W:
www.skin.brad.ac.uk
Campo Research Group with EthnoBotany, Botanical Collection, For further information, please visit our stand.
Growing, Harvesting and Extraction and Processing of Natural For further information, please visit our stand.
Product Chemistry in both Bulk multi-tonnage and Research &
Development bench-scale quantities of Natural Colors, Natural
Plant Based Preservatives, Natural Active Ingredients such as
Kinetin, Co-Enzyme Q10, DMAE, Alpha-Lipoic Acids, and many
new novel Bio-Phyto based Molecules for the Cosmetic and
Personal Care Industries. Campo Research facilities are
strategically located in Brazil, India, China, Malaysia, Czech
Republic and in the US, to service the cosmetic and personal
care industries with unique Natural Green Active Ingredients.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188